CDEK
← All organizations
Sun Pharmaceuticals

Sun Pharmaceuticals

For profitContributed to NMEWebsite ↗

Also known as: SPIL | SUN PHARM | Sun Pharmaceutical Industries Limited | SUN PHARMACEUTICAL INDUSTRIES LIMITED | Sun Pharmaceutical Industries Ltd | Sun Pharmaceuticals Industries Limited | SUN PHARMA GLOBAL | Sun Pharma Global FZE | SunPharm Corp | SUN PHARM INDS | SUN PHARM INDS (IN) | SUN PHARM INDS INC | SUN PHARM INDS LTD | SUN PHARM INDUSTRIES | TIAN JIN CHASE SUN PHARMACEUTICAL CO.,LTD

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Dec 1, 2004

First marketed drug

Jul 1, 1983

First NDA

Apr 24, 1985

Last known activity

Mar 24, 2026

Timeline

1980s

  1. Jul 1, 1983

    Sun Pharmaceuticals— Founded

1990s

  1. Dec 17, 1990

    ulobetasol propionate— NDA Organization

  2. Jan 1, 1997

    Caraco Pharmaceutical Laboratories— Acquired

2010s

  1. Jan 1, 2012

    DUSA Pharmaceuticals— Acquired

  2. Jan 1, 2014

    Pharmalucence— Acquired

  3. Apr 6, 2014

    Ranbaxy— Acquired

  4. Jan 1, 2015

    InSite Vision— Acquired

  5. Jan 1, 2015

    Zalicus— Acquired

  6. Apr 8, 2016

    bromfenac— NDA Secondary Org

  7. Dec 15, 2016

    Ocular Technologies SARL— Acquired

  8. Apr 6, 2018

    paliperidone— Marketing Organization

2020s

  1. Jan 19, 2024

    Taro Pharmaceuticals— Acquired

Drugs by trial phase (141 distinct, 315 trials)

Indications

Approved for

Studied for

Marketed drugs (389)

Subsidiaries (9 direct, 12 total across the full acquisition tree)

Recent trials (50)

Details

Founded
Vapi, Gujarat, IN Jul 1, 1983
First NDA
Apr 24, 1985
Last known activity
Mar 24, 2026

Designations held

  • Orphan drug
  • Fast track
  • Priority review